Circulating tumor cells (CTC) and KRAS mutant circulating free DNA (cfDNA) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer

BACKGROUND: Pancreatic cancer remains one of the most difficult cancers to treat with the poorest prognosis. The key to improving survival rates in this disease is early detection and monitoring of disseminated and residual disease. However, this is hindered due to lack reliable diagnostic and predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Earl, Julie, Garcia-Nieto, Sandra, Martinez-Avila, Jose Carlos, Montans, José, Sanjuanbenito, Alfonso, Rodríguez-Garrote, Mercedes, Lisa, Eduardo, Mendía, Elena, Lobo, Eduardo, Malats, Núria, Carrato, Alfredo, Guillen-Ponce, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619983/
https://www.ncbi.nlm.nih.gov/pubmed/26498594
http://dx.doi.org/10.1186/s12885-015-1779-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619983/
https://www.ncbi.nlm.nih.gov/pubmed/26498594
http://dx.doi.org/10.1186/s12885-015-1779-7

Ejemplares similares